NCT01925378 2020-11-12
A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia
The University of Texas Health Science Center, Houston
Phase 2 Withdrawn
The University of Texas Health Science Center, Houston
DFB Soria, LLC
SWOG Cancer Research Network